123 related articles for article (PubMed ID: 35312295)
21. Gold-coated iron oxide nanoparticles as a T2 contrast agent in magnetic resonance imaging.
Ahmad T; Bae H; Rhee I; Chang Y; Jin SU; Hong S
J Nanosci Nanotechnol; 2012 Jul; 12(7):5132-7. PubMed ID: 22966533
[TBL] [Abstract][Full Text] [Related]
22. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
23. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles.
Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L
J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672
[TBL] [Abstract][Full Text] [Related]
24. Facile Synthesis of Folic Acid-Modified Iron Oxide Nanoparticles for Targeted MR Imaging in Pulmonary Tumor Xenografts.
Zhang Z; Hu Y; Yang J; Xu Y; Zhang C; Wang Z; Shi X; Zhang G
Mol Imaging Biol; 2016 Aug; 18(4):569-78. PubMed ID: 26620721
[TBL] [Abstract][Full Text] [Related]
25. Biomineralized iron oxide-polydopamine hybrid nanodots for contrast-enhanced
Wang Z; Wang Y; Wang Y; Wei C; Deng Y; Chen H; Shen J; Ke H
J Mater Chem B; 2021 Feb; 9(7):1781-1786. PubMed ID: 33594402
[TBL] [Abstract][Full Text] [Related]
26. Integrin-Targeted Theranostic Nanoparticles for Clinical MRI-Traceable Treatment of Liver Fibrosis.
Hu Q; Su Y; Ma S; Wei P; He C; Yang D; Qian Y; Shen Y; Zhou X; Zhou Z; Hu H
ACS Appl Mater Interfaces; 2024 Jan; 16(2):2012-2026. PubMed ID: 38165274
[TBL] [Abstract][Full Text] [Related]
27. Size-dependent ferrohydrodynamic relaxometry of magnetic particle imaging tracers in different environments.
Arami H; Ferguson RM; Khandhar AP; Krishnan KM
Med Phys; 2013 Jul; 40(7):071904. PubMed ID: 23822441
[TBL] [Abstract][Full Text] [Related]
28. In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration.
Tzameret A; Ketter-Katz H; Edelshtain V; Sher I; Corem-Salkmon E; Levy I; Last D; Guez D; Mardor Y; Margel S; Rotenstrich Y
J Nanobiotechnology; 2019 Jan; 17(1):3. PubMed ID: 30630490
[TBL] [Abstract][Full Text] [Related]
29. Manganese-Based Magnetic Layered Double Hydroxide Nanoparticle: A pH-Sensitive and Concurrently Enhanced
Xie W; Guo Z; Cao Z; Gao Q; Wang D; Boyer C; Kavallaris M; Sun X; Wang X; Zhao L; Gu Z
ACS Biomater Sci Eng; 2019 May; 5(5):2555-2562. PubMed ID: 33405761
[TBL] [Abstract][Full Text] [Related]
30. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
[TBL] [Abstract][Full Text] [Related]
31. EDTMP ligand-enhanced water interactions endowing iron oxide nanoparticles with dual-modal MRI contrast ability.
Hao L; Wang P; Wu Z; Wang Z; Wang Y; Zhu Y; Xu Z; Guo M; Ji J; Zhang P
J Mater Chem B; 2021 Nov; 9(43):9055-9066. PubMed ID: 34673872
[TBL] [Abstract][Full Text] [Related]
32. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous magnetically directed drug convection and MR imaging.
Yathindranath V; Hegmann T; van Lierop J; Potter K; Fowler CB; Moore DF
Nanotechnology; 2009 Oct; 20(40):405101. PubMed ID: 19738300
[TBL] [Abstract][Full Text] [Related]
34. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
Peng XH; Qian X; Mao H; Wang AY; Chen ZG; Nie S; Shin DM
Int J Nanomedicine; 2008; 3(3):311-21. PubMed ID: 18990940
[TBL] [Abstract][Full Text] [Related]
35. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment.
Tsiapa I; Efthimiadou EK; Fragogeorgi E; Loudos G; Varvarigou AD; Bouziotis P; Kordas GC; Mihailidis D; Nikiforidis GC; Xanthopoulos S; Psimadas D; Paravatou-Petsotas M; Palamaris L; Hazle JD; Kagadis GC
J Colloid Interface Sci; 2014 Nov; 433():163-175. PubMed ID: 25128864
[TBL] [Abstract][Full Text] [Related]
36. Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer.
Wang D; Fei B; Halig LV; Qin X; Hu Z; Xu H; Wang YA; Chen Z; Kim S; Shin DM; Chen ZG
ACS Nano; 2014 Jul; 8(7):6620-32. PubMed ID: 24923902
[TBL] [Abstract][Full Text] [Related]
37. Fluorescent carbon dots tailored iron oxide nano hybrid system for
Nazeer SS; Saraswathy A; Nimi N; Sarathkumar E; Resmi AN; Shenoy SJ; Jayasree RS
Methods Appl Fluoresc; 2023 Mar; 11(2):. PubMed ID: 36854197
[TBL] [Abstract][Full Text] [Related]
38. Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: synthesis, characterization, and in vivo application.
Tegafaw T; Xu W; Ahmad MW; Baeck JS; Chang Y; Bae JE; Chae KS; Kim TJ; Lee GH
Nanotechnology; 2015 Sep; 26(36):365102. PubMed ID: 26291827
[TBL] [Abstract][Full Text] [Related]
39. Facile synthesis of superparamagnetic nickel-doped iron oxide nanoparticles as high-performance
Lu C; Xu X; Zhang T; Wang Z; Chai Y
J Mater Chem B; 2022 Mar; 10(10):1623-1633. PubMed ID: 35191907
[TBL] [Abstract][Full Text] [Related]
40. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
